Texas A&M Football Recruiting

Live Press Conference Notes: Mike Elko discusses Early Signing Day 2025

The Early Signing Period began on Wednesday morning, and the Aggies received signatures from all of their commitments. Follow along as TexAgs provides live updates of Mike Elko's media availability discussing Texas A&M's new signees.
By Kay Naegeli
December 3, 2025
4.6k Views
Discuss

The following are live, paraphrased notes from Mike Elko’s Wednesday afternoon conference. As always, please forgive any typos, our goal is keeping up over accuracy on the first run.

Mike Elko

  • Today is an exciting day around the country. It’s a special day. A lot of kids dream about it. Congrats to all those kids who got to enjoy it. From our perspective, we feel it's a really good class. What we were proud of was how strong and early the commitments were.
To continue reading, you must be a TexAgs Premium subscriber.
Try Premium for $1
See Subscription Benefits →
Trial only available to users who have never subscribed or participated in a previous trial
Discuss
Tags
Mike Elko Press Conferences Early Signing Period Live Press Conference Notes Early Signing Period 2025 Kaeden Johnson Tank King Hunter McKinney KJ Edwards Bryce Perry-Wright Aaron Gregory Zaden Krempin
Show All
Madden Williams Mike Brown Avery Morcho Daquives Beck Jermaine Kinsler Samu Moala Brandon Arrington Storm Miller Helaman Casuga Evan Jacobson Caleb Tafua Samuel Roseborough Jayden Warren Chance Collins Tylan Wilson Victor Singleton Tamarion Watkins Asher Murray Waylon Peters Football Recruiting Texas A&M 2025 2026
SPONSORED BY
EventPipe
More Football Recruiting
See All →
OL signee Avery Morcho thankful for the support along his path to A&M
By Cade Draughon
Standout safety Chance Collins is 'glad' with his Texas A&M decision
By Jason Howell
WATCH HERE: Early Signing Day Show
By TexAgs
WR signee Jayden Warren ready to put in work in Maroon & White
By Cade Draughon
 
×
subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.